Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026)

Envista Holdings' (NVST) quarterly Cash from Investing Activities came in at -$68.9 million in Q2 2026, down 682.95% year-on-year from $11.8 million in Q2 2025, and down 344.52% quarter-over-quarter from -$15.5 million in Q4 2025.

Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Envista Holdings' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$68.9 million for Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 682.95% year-over-year to -$68.9 million in Q2 2026; TTM through Apr 2026 was -$111.2 million, a 111.01% decrease from a year earlier, with the FY2025 full-year figure at -$51.1 million, up 6.41% from the prior year.
  • Cash from Investing Activities slipped to -$68.9 million in Q2 2026 per NVST's latest filing, from -$15.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $5.1 million in Q2 2022 and bottomed at -$591.6 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$12.6 million (2023), against an average of -$52.6 million.
  • Biggest YoY gain for Cash from Investing Activities was 192.73% in 2022; the steepest drop was 3319.65% in 2022.
  • Year by year, Cash from Investing Activities stood at -$1.1 million in 2022, then slumped by 1045.45% to -$12.6 million in 2023, then jumped by 41.27% to -$7.4 million in 2024, then tumbled by 109.46% to -$15.5 million in 2025, then slumped by 344.52% to -$68.9 million in 2026.
  • Per Business Quant, the three latest NVST Cash from Investing Activities figures stand at -$68.9 million (Q2 2026), -$15.5 million (Q4 2025), and -$9.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 125.34 Bn 120.12 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 44.60 Bn 43.79 Bn 2.15 Bn -139.00 Mn
3 Alcon 33.17 Bn 31.51 Bn 1.53 Bn -218.00 Mn
4 Medline 32.71 Bn 30.48 Bn 1.84 Bn -96.00 Mn
5 Resmed 29.12 Bn 27.46 Bn 890.98 Mn -58.03 Mn
6 West Pharmaceutical Services 23.75 Bn 23.31 Bn 329.20 Mn -43.20 Mn
7 Solventum 13.94 Bn 13.38 Bn 1.10 Bn -77.00 Mn
8 Cooper Companies 13.90 Bn 13.77 Bn 735.40 Mn -90.00 Mn
9 Align Technology 12.06 Bn 11.00 Bn 736.59 Mn -131.58 Mn
10 Envista Holdings 4.36 Bn 3.27 Bn 390.10 Mn -68.90 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -68.90 Mn
Apr 3, 2026 -68.90 Mn
Dec 31, 2025 -15.50 Mn
Dec 31, 2025 -15.50 Mn
Sep 26, 2025 -9.70 Mn
Sep 26, 2025 -9.70 Mn
Jun 27, 2025 -17.10 Mn
Jun 27, 2025 -17.10 Mn
Mar 28, 2025 -8.80 Mn
Mar 28, 2025 -8.80 Mn
Dec 31, 2024 -7.40 Mn
Dec 31, 2024 -7.40 Mn
Sep 27, 2024 -30.60 Mn
Sep 27, 2024 -30.60 Mn
Jun 28, 2024 -5.90 Mn
Jun 28, 2024 -5.90 Mn
Mar 29, 2024 -10.70 Mn
Mar 29, 2024 -10.70 Mn
Dec 31, 2023 -12.60 Mn
Dec 31, 2023 -12.60 Mn